Lori Anne Kunkel Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lori Anne Kunkel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lori Anne Kunkel. Lori Anne Kunkel is Chief Medical Officer in PHARMACYCLICS INC ($PCYC) and Director in CURIS INC ($CRIS) and Acting-Chief Medical Officer in Tocagen Inc ($TOCA) and Director in Tocagen Inc ($TOCA) and Director in Loxo Oncology, Inc. ($LOXO) and Director in Oric Pharmaceuticals, Inc. ($ORIC).
Latest Insider Trading Transactions of Lori Anne Kunkel
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRIS, TOCA, LOXO, ORIC, PCYC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | ORIC | Oric Pharmaceutica ... | Kunkel Lori Anne | Director | Option Exercise | A | 19.03 | 16,625 | 316,374 | 16,625 | |
| Jun 10 2020 | ORIC | Oric Pharmaceutica ... | Kunkel Lori Anne | Director | Option Exercise | A | 35.92 | 28,515 | 1,024,259 | 28,515 | |
| Mar 04 2020 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | A | 1.26 | 180,000 | 226,800 | 180,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
| May 31 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 4.22 | 20,000 | 84,400 | 20,000 | |
| Feb 26 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Acting-Chief Medica ... | Option Exercise | A | 9.27 | 35,000 | 324,450 | 35,000 | |
| Feb 26 2019 | TOCA | Tocagen Inc | Kunkel Lori Anne | Acting-Chief Medica ... | Option Exercise | A | 9.27 | 35,000 | 324,450 | 35,000 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | D | 180.98 | 8,750 | 1,583,575 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | D | 78.58 | 11,000 | 864,380 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | D | 24.18 | 3,095 | 74,837 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | D | 20.91 | 4,716 | 98,612 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | D | 3.65 | 49,687 | 181,258 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | D | 3.65 | 27,344 | 99,751 | 0 | |
| Jan 25 2019 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Sell | S | 1.05 | 14,800 | 15,581 | 22,200 | 37 K to 22.2 K (-40.00 %) |
| Jan 23 2019 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | A | 1.16 | 180,000 | 208,800 | 180,000 | |
| Jan 23 2019 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | A | 1.16 | 180,000 | 208,800 | 180,000 | |
| Oct 03 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | M | 3.65 | 5,000 | 18,240 | 22,344 | |
| Oct 03 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 171.90 | 500 | 85,948 | 0 | 500 to 0 (-100.00 %) |
| Oct 03 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 170.20 | 4,500 | 765,881 | 500 | 5 K to 500 (-90.00 %) |
| Oct 03 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Buy | M | 3.65 | 5,000 | 18,240 | 5,000 | 0 to 5 K |
| Jun 25 2018 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 8.98 | 20,000 | 179,600 | 20,000 | |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | M | 24.18 | 1,953 | 47,224 | 5,859 | |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | M | 20.91 | 3,096 | 64,737 | 4,716 | |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | M | 3.65 | 27,343 | 99,747 | 27,344 | |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 177.79 | 4 | 711 | 0 | 4 to 0 (-100.00 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 177.12 | 5,601 | 992,059 | 4 | 5.6 K to 4 (-99.93 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 175.64 | 1,235 | 216,920 | 5,605 | 6.8 K to 5.6 K (-18.06 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 182.35 | 1,541 | 280,996 | 6,840 | 8.4 K to 6.8 K (-18.39 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 181.48 | 2,411 | 437,544 | 8,381 | 10.8 K to 8.4 K (-22.34 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 180.28 | 28,440 | 5,127,024 | 10,792 | 39.2 K to 10.8 K (-72.49 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Buy | M | 24.18 | 1,953 | 47,224 | 39,232 | 37.3 K to 39.2 K (+5.24 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Buy | M | 20.91 | 3,096 | 64,737 | 37,279 | 34.2 K to 37.3 K (+9.06 %) |
| Jun 18 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Buy | M | 3.65 | 27,343 | 99,747 | 34,183 | 6.8 K to 34.2 K (+399.75 %) |
| Jun 14 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | A | 180.98 | 8,750 | 1,583,575 | 8,750 | |
| Apr 24 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 133.60 | 100 | 13,360 | 6,840 | 6.9 K to 6.8 K (-1.44 %) |
| Apr 24 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 132.81 | 4,000 | 531,239 | 6,940 | 10.9 K to 6.9 K (-36.56 %) |
| Apr 24 2018 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 131.98 | 900 | 118,779 | 10,940 | 11.8 K to 10.9 K (-7.60 %) |
| Jan 24 2018 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Grant | A | 0.00 | 185,000 | 0 | 185,000 | 0 to 185 K |
| Nov 06 2017 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 86.28 | 400 | 34,511 | 11,840 | 12.2 K to 11.8 K (-3.27 %) |
| Nov 06 2017 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 85.21 | 2,800 | 238,591 | 12,240 | 15 K to 12.2 K (-18.62 %) |
| Nov 06 2017 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 84.15 | 1,800 | 151,469 | 15,040 | 16.8 K to 15 K (-10.69 %) |
| Aug 23 2017 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Sell | S | 75.17 | 10,000 | 751,731 | 16,840 | 26.8 K to 16.8 K (-37.26 %) |
| Jun 23 2017 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | A | 78.58 | 11,000 | 864,380 | 11,000 | |
| Apr 12 2017 | TOCA | Tocagen Inc | Kunkel Lori Anne | Director | Option Exercise | A | 10.00 | 4,528 | 45,280 | 4,528 | |
| Mar 02 2017 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | A | 2.31 | 120,000 | 277,200 | 120,000 | |
| Nov 14 2016 | CRIS | CURIS INC | Kunkel Lori Anne | Director | Option Exercise | A | 3.36 | 25,000 | 84,000 | 25,000 | |
| Jun 13 2016 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | A | 24.18 | 7,812 | 188,894 | 7,812 | |
| Jul 30 2015 | LOXO | Loxo Oncology, Inc ... | Kunkel Lori Anne | Director | Option Exercise | A | 20.91 | 7,812 | 163,349 | 7,812 | |
| May 01 2013 | PCYC | PHARMACYCLICS INC | Kunkel Lori Anne | Chief Medical Offic ... | Buy | J | 23.07 | 921 | 21,247 | 2,842 | 1.9 K to 2.8 K (+47.94 %) |
| Nov 02 2012 | PCYC | PHARMACYCLICS INC | Kunkel Lori Anne | Chief Medical Offic ... | Buy | J | 23.07 | 921 | 21,247 | 1,921 | 1,000 to 1.9 K (+92.10 %) |
| Dec 05 2011 | PCYC | PHARMACYCLICS INC | Kunkel Lori Anne | Chief Medical Offic ... | Option Exercise | A | 14.92 | 300,000 | 4,476,000 | 300,000 |
Page: 1